COSMOFER

This brand name is authorized in Estonia, Ireland, Lithuania, Netherlands, Poland, South Africa, Spain, UK.

Active ingredients

The drug COSMOFER contains one active pharmaceutical ingredient (API):

1
UNII 95HR524N2M - IRON DEXTRAN
 
Read more about Iron dextran

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B03AC Iron trivalent, parenteral preparations B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1229004, 1229015, 1229026, 1311028, 1311039
ES Centro de información online de medicamentos de la AEMPS 68243
GB Medicines & Healthcare Products Regulatory Agency 136291, 45546
IE Health Products Regulatory Authority 18699, 18700
LT Valstybinė vaistų kontrolės tarnyba 1004833, 1022347, 1022348, 1050858, 1050859, 1073222, 1082491
NL Z-Index G-Standaard 14684322
NL Z-Index G-Standaard, PRK 78948
PL Rejestru Produktów Leczniczych 100123403
ZA Health Products Regulatory Authority 37/8.3/0434

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈